A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study

Background: Prevention of the vertical transmission of the hepatitis C virus (HCV) presents an obstetric challenge. There are no approved antiviral medications for the treatment or prevention of HCV for pregnant patients. Objective: We aimed to create a composite score to accurately identify a popul...

Full description

Bibliographic Details
Main Authors: Paul Wasuwanich, Joshua M. So, Brett Presnell, Wikrom Karnsakul, Robert S. Egerman, Tony S. Wen
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/13/1/45
_version_ 1797342786068938752
author Paul Wasuwanich
Joshua M. So
Brett Presnell
Wikrom Karnsakul
Robert S. Egerman
Tony S. Wen
author_facet Paul Wasuwanich
Joshua M. So
Brett Presnell
Wikrom Karnsakul
Robert S. Egerman
Tony S. Wen
author_sort Paul Wasuwanich
collection DOAJ
description Background: Prevention of the vertical transmission of the hepatitis C virus (HCV) presents an obstetric challenge. There are no approved antiviral medications for the treatment or prevention of HCV for pregnant patients. Objective: We aimed to create a composite score to accurately identify a population of pregnant patients with HCV who have high potential for vertical transmission. Study Design: In a retrospective, multicenter cohort study, we identified pregnant patients with hepatitis C with linked data to their infants who have had HCV RNA or HCV antibody testing. Demographic data, including age and race/ethnicity, as well as clinical and laboratory data, including tobacco/alcohol use, infections, liver function tests, the HCV RNA titer, HCV antibody, HCV genotype, absolute lymphocyte count, and platelet count, were collected. Data were analyzed using logistic regression and receiver operating characteristics (ROCs) and internally validated using the forward selection bootstrap method. Results: We identified 157 pregnant patients and 163 corresponding infants. The median maternal delivery age was 29 (IQR: 25–33) years, and the majority (141, or 89.8%) were White. A high HCV RNA titer, high absolute lymphocyte count, and high platelet count were associated with vertical transmission. A high HCV RNA titer had an AUROC of 0.815 with sensitivity, specificity, a positive predictive value, and a negative predictive value of 100.0%, 59.1%, 17.6%, and 100.0%, respectively. A composite score combining the three risk factors had an AUROC of 0.902 (95% CI = 0.840–0.964) but with a risk of overfitting. Conclusions: An HCV RNA titer alone or a composite score combining the risk factors for HCV vertical transmission can potentially identify a population of pregnant patients where the rate of vertical transmission is high, allowing for potential interventions during antepartum care.
first_indexed 2024-03-08T10:38:18Z
format Article
id doaj.art-4f649e1bd9094aecb425fd4182bcd7f7
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-08T10:38:18Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-4f649e1bd9094aecb425fd4182bcd7f72024-01-26T18:03:24ZengMDPI AGPathogens2076-08172024-01-011314510.3390/pathogens13010045A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter StudyPaul Wasuwanich0Joshua M. So1Brett Presnell2Wikrom Karnsakul3Robert S. Egerman4Tony S. Wen5University of Florida College of Medicine, Gainesville, FL 32610, USAUniversity of Florida College of Medicine, Gainesville, FL 32610, USADepartment of Statistics, University of Florida, Gainesville, FL 32611, USADivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADivision of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Florida College of Medicine, Gainesville, FL 32610, USADivision of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Florida College of Medicine, Gainesville, FL 32610, USABackground: Prevention of the vertical transmission of the hepatitis C virus (HCV) presents an obstetric challenge. There are no approved antiviral medications for the treatment or prevention of HCV for pregnant patients. Objective: We aimed to create a composite score to accurately identify a population of pregnant patients with HCV who have high potential for vertical transmission. Study Design: In a retrospective, multicenter cohort study, we identified pregnant patients with hepatitis C with linked data to their infants who have had HCV RNA or HCV antibody testing. Demographic data, including age and race/ethnicity, as well as clinical and laboratory data, including tobacco/alcohol use, infections, liver function tests, the HCV RNA titer, HCV antibody, HCV genotype, absolute lymphocyte count, and platelet count, were collected. Data were analyzed using logistic regression and receiver operating characteristics (ROCs) and internally validated using the forward selection bootstrap method. Results: We identified 157 pregnant patients and 163 corresponding infants. The median maternal delivery age was 29 (IQR: 25–33) years, and the majority (141, or 89.8%) were White. A high HCV RNA titer, high absolute lymphocyte count, and high platelet count were associated with vertical transmission. A high HCV RNA titer had an AUROC of 0.815 with sensitivity, specificity, a positive predictive value, and a negative predictive value of 100.0%, 59.1%, 17.6%, and 100.0%, respectively. A composite score combining the three risk factors had an AUROC of 0.902 (95% CI = 0.840–0.964) but with a risk of overfitting. Conclusions: An HCV RNA titer alone or a composite score combining the risk factors for HCV vertical transmission can potentially identify a population of pregnant patients where the rate of vertical transmission is high, allowing for potential interventions during antepartum care.https://www.mdpi.com/2076-0817/13/1/45pregnancyantiviral agentspublic healthlymphocytes
spellingShingle Paul Wasuwanich
Joshua M. So
Brett Presnell
Wikrom Karnsakul
Robert S. Egerman
Tony S. Wen
A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study
Pathogens
pregnancy
antiviral agents
public health
lymphocytes
title A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study
title_full A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study
title_fullStr A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study
title_full_unstemmed A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study
title_short A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study
title_sort composite score for predicting vertical transmission of hepatitis c a multicenter study
topic pregnancy
antiviral agents
public health
lymphocytes
url https://www.mdpi.com/2076-0817/13/1/45
work_keys_str_mv AT paulwasuwanich acompositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT joshuamso acompositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT brettpresnell acompositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT wikromkarnsakul acompositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT robertsegerman acompositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT tonyswen acompositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT paulwasuwanich compositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT joshuamso compositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT brettpresnell compositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT wikromkarnsakul compositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT robertsegerman compositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy
AT tonyswen compositescoreforpredictingverticaltransmissionofhepatitiscamulticenterstudy